New hope for advanced tumors: JSKN003 enters human trials
NCT ID NCT05744427
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study tests a new drug called JSKN003 in Chinese adults with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to find the safest dose and see if the drug can shrink tumors. About 725 participants will receive the drug intravenously every three weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Cancer Hospital of Fudan University
Shanghai, China
-
Affiliated Cancer Hospital of Guangxi Medical University
Nanning, China
-
Affiliated Cancer Hospital of Harbin Medical University
Ha’erbin, China
-
Affiliated Hospital of Qingdao University
Qingdao, China
-
Anhui Provincal Hospital
Hefei, China
-
Beijing Cancer Hospital
Beijing, China
-
Beijing Friendship Hospital
Beijing, China
-
Beijing Luhe Hospital
Beijing, China
-
Changhai Hospital
Shanghai, China
-
Fudan University Shanghai Cancer Center
Shanghai, China
-
Fujian Cancer Hospital
Fuzhou, China
-
Gulou Hospital Affiliated to Nanjing University School of Medicine
Nanjing, China
-
Hunan Cancer Hospital
Changsha, China
-
Jiangsu Cancer Hospital
Nanjing, China
-
Jiangsu Provincial People's Hospital
Nanjing, China
-
Linyi City Cancer Hospital
Linyi, China
-
Linyi City People's Hospital
Linyi, China
-
Nantong Cancer Hospital
Nantong, China
-
Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
-
Shandong Cancer Hospital
Jinan, China
-
Shanghai East Hospital
Shanghai, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, China
-
Sun Yat-sen University Cancer Prevention Center
Guangzhou, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, China
-
The First Affiliated Hospital of Nanjing Medical University/Jiangsu Provincial People's Hospital
Nanjing, China
-
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
-
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
-
Xuzhou Central Hospital
Xuzhou, China
-
Zhejiang Cancer Hospital
Hangzhou, China
-
Zhongnan Hospital of Wuhan University
Wuhan, China
Conditions
Explore the condition pages connected to this study.